New gastritis pill faces off against standard treatment in 470-Patient trial
NCT ID NCT07631065
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a new tablet called Sto M Tab. works as well as the standard treatment Stillen Tab. for people with acute or chronic gastritis (stomach lining inflammation). About 470 adults aged 19-75 will take one of the two tablets for 2 weeks. The main goal is to see if stomach erosions improve by at least 50% on camera examination.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE GASTRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New gastritis drug candidate tested in three formulations to find the best acid controller
- Simpler h. pylori treatment could reduce antibiotic use
- Could one pill a day replace three for stomach upset?
- Gastritis drug showdown: which version works better?
- Tiny biopsy could sharpen stomach disease detection
- Gum bacteria linked to stomach troubles? small study investigates